| Dr Darrell Robin Hoppes Jr, DPM | |
|
6100 Old Jonestown Rd, Harrisburg, PA 17112-2607 | |
| (717) 541-0988 | |
| (717) 412-4882 |
| Full Name | Dr Darrell Robin Hoppes Jr |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 14 Years |
| Location | 6100 Old Jonestown Rd, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255642500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 006520 (New York) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | SC006195 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Keystone Podiatric Medical Associates Pc | 8527038363 | 5 |
News Archive
Mylan Inc. today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
McClatchy/Chicago Tribune examines the "worst drought in 30 years" in Guatemala, which "has destroyed 80 percent of the region's crops and claimed the lives of more than a dozen children so far this year."
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
› Verified 9 days ago
| Provider Name | Keystone Podiatric Medical Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376608430 PECOS PAC ID: 8527038363 Enrollment ID: O20040728001403 |
News Archive
Mylan Inc. today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
McClatchy/Chicago Tribune examines the "worst drought in 30 years" in Guatemala, which "has destroyed 80 percent of the region's crops and claimed the lives of more than a dozen children so far this year."
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
› Verified 9 days ago
| Provider Name | Penn State Health Community Medical Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Mylan Inc. today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
McClatchy/Chicago Tribune examines the "worst drought in 30 years" in Guatemala, which "has destroyed 80 percent of the region's crops and claimed the lives of more than a dozen children so far this year."
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darrell Robin Hoppes Jr, DPM 135 Stonebrook Dr, Palmyra, PA 17078-4410 Ph: (610) 462-5563 | Dr Darrell Robin Hoppes Jr, DPM 6100 Old Jonestown Rd, Harrisburg, PA 17112-2607 Ph: (717) 541-0988 |
News Archive
Mylan Inc. today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally occurring agent derived from bacteria.
McClatchy/Chicago Tribune examines the "worst drought in 30 years" in Guatemala, which "has destroyed 80 percent of the region's crops and claimed the lives of more than a dozen children so far this year."
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
› Verified 9 days ago
Onhealthcare Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2595 Interstate Dr Ste 103, Harrisburg, PA 17110 Phone: 502-244-2420 Fax: 724-759-7111 | |
Dr. Brian Alan Dechowitz, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 127 Pine St, Harrisburg, PA 17101 Phone: 717-238-1445 Fax: 717-238-1446 | |
Dr. James William Ritter, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 6100 Old Jonestown Rd, Harrisburg, PA 17112 Phone: 171-754-1098 Fax: 215-823-4434 | |
Edward A Rosboschil Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 845 Sir Thomas Ct, Harrisburg, PA 17109 Phone: 717-657-2280 | |
Louis Vernon Greer, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4230 Crums Mill Rd, Harrisburg, PA 17112 Phone: 717-657-5050 Fax: 717-657-9350 | |
Daniel Yarmel, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4033 Linglestown Rd, Suite 1, Harrisburg, PA 17112 Phone: 717-651-0000 | |
Dr. Allan B. Grossman, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4033 Linglestown Rd, Harrisburg, PA 17112 Phone: 717-651-0000 Fax: 717-651-0001 |